Search
Glycocholic acid
go.drugbank.com/drugs/DB02691InvestigationalIt acts as a detergent to solubilize fats for absorption and is itself absorbed.
Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester
go.drugbank.com/drugs/DB01774ExperimentalServes as the glycosyl donor for formation of bacterial glycogen, amylose in green algae, and amylopectin in higher plants. [PubChem]
ATX-101
go.drugbank.com/drugs/DB05780InvestigationalDeoxycholic acid is a naturally occurring bile acid produced by the liver as one of several end products of cholesterol metabolism. … ATX-101 (medical), sodium deoxycholate for subcutaneous injection, is being evaluated as a treatment for the reduction of localized fat deposits.
Odronextamab
go.drugbank.com/drugs/DB16684ApprovedInvestigationalThe partial clinical hold was later lifted in May 2021. … [A254192] Odronextamab received its first approval in the European Union on August 26, 2024, for the treatment of relapsed or refractory (R/R) follicular lymphoma (FL) or R/R diffuse large B-cell lymphoma
Cephalothin Group
go.drugbank.com/drugs/DB03450ExperimentalThese are organic compounds containing 1,3-thiazine, a six-member ring with a nitrogen and a sulfur atom in ring positions 1 and 3 respectively, as well as two double bonds.
Anisomycin
go.drugbank.com/drugs/DB07374ExperimentalAnisomycin (sometimes known as flagecidin), is an antibiotic retrieved from the bacteria _Streptomyces griseolus_. This drug acts to inhibit bacterial protein and DNA synthesis.
Trifluoroethanol
go.drugbank.com/drugs/DB03226ExperimentalA non-aqueous co-solvent that serves as tool to study protein folding. It is also used in various pharmaceutical, chemical and engineering applications.
OXI-4503
go.drugbank.com/drugs/DB05143Investigationaldemonstrates that OXI-4503 is metabolized by oxidative enzymes (e.g., tyrosinase and peroxidases), which are elevated in many solid tumors and tumor infiltrates, to an orthoquinone chemical species that has … Preclinical studies have demonstrated that OXI-4503 has (i) single-agent activity against a range of xenograft tumor models; and (ii) synergistic or additive effects when incorporated in various combination
Firocoxib
go.drugbank.com/drugs/DB09217ExperimentalVet approvedFirocoxib was the first COX-2 inhibitor approved by the U.S. Food and Drug Administration for horses. Firocoxib is not intended or approved for use in human medicine.
Azelnidipine
go.drugbank.com/drugs/DB09230InvestigationalIt has a gradual onset of action and produces a long-lasting decrease in blood pressure, with only a small increase in heart rate, unlike some other calcium channel blockers [L1379].